AlphaYouKM
Congress trade
Rep. Kathy Manning (D-NC) sold $1K-$15K of Biogen Inc. (BIIB) stock
Kathy Manning, U.S. Representative (D-NC), disclosed a sale of Biogen Inc. (BIIB) stock worth $1K-$15K in a STOCK Act filing on Feb 11, 2022.
The trade happened on Jan 14, 2022, 28 days before it was made public.
BIIB has moved -8.1% since the trade date, from $239.30 to $219.88 (Oct 2, 2026 close).
- Traded
- Jan 14, 2022
- Disclosed
- Feb 11, 2022
- Filing delay
- 28 days
- Price since
- -8.1%
- Source
- STOCK Act disclosure
Other trades in this disclosure (52)
- SellEL$15K-$50KFeb 11, 2022
- SellINFO$15K-$50KFeb 11, 2022
- SellINFO$15K-$50KFeb 11, 2022
- BuyMTCH$15K-$50KFeb 11, 2022
- SellNVDA$15K-$50KFeb 11, 2022
- BuyPYPL$15K-$50KFeb 11, 2022
- SellPYPL$15K-$50KFeb 11, 2022
- SellSNAP$15K-$50KFeb 11, 2022
- BuyV$15K-$50KFeb 11, 2022
- BuyADBE$1K-$15KFeb 11, 2022
- SellAMZN$1K-$15KFeb 11, 2022
- BuyCME$1K-$15KFeb 11, 2022
- BuyCME$1K-$15KFeb 11, 2022
- BuyCMG$1K-$15KFeb 11, 2022
- SellFB$1K-$15KFeb 11, 2022
- SellILMN$1K-$15KFeb 11, 2022
- BuyILMN$1K-$15KFeb 11, 2022
- BuyILMN$1K-$15KFeb 11, 2022
- BuyILMN$1K-$15KFeb 11, 2022
- SellINFO$1K-$15KFeb 11, 2022
More BIIB insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.